Business Description
AC Immune SA
NAICS : 325412
SIC : 2834
ISIN : CH0329023102
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 29.47 | |||||
Equity-to-Asset | 0.88 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.07 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | 2.95 | |||||
Beneish M-Score | 4.3 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -5.8 | |||||
3-Year EBITDA Growth Rate | 8.9 | |||||
3-Year EPS without NRI Growth Rate | 6.7 | |||||
3-Year FCF Growth Rate | 4.4 | |||||
3-Year Book Growth Rate | -17.8 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 17.06 | |||||
9-Day RSI | 23.51 | |||||
14-Day RSI | 29.81 | |||||
6-1 Month Momentum % | 14.43 | |||||
12-1 Month Momentum % | 58.08 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 9.22 | |||||
Quick Ratio | 9.22 | |||||
Cash Ratio | 7.59 | |||||
Days Sales Outstanding | 364.98 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -11.3 | |||||
Shareholder Yield % | -0.12 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -345.92 | |||||
Net Margin % | -350.2 | |||||
FCF Margin % | -403.18 | |||||
ROE % | -36.25 | |||||
ROA % | -32.36 | |||||
ROIC % | -89.03 | |||||
ROC (Joel Greenblatt) % | -647.78 | |||||
ROCE % | -34.68 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 12.03 | |||||
PB Ratio | 1.27 | |||||
Price-to-Tangible-Book | 1.82 | |||||
EV-to-EBIT | -1.97 | |||||
EV-to-Forward-EBIT | -1.71 | |||||
EV-to-EBITDA | -2.06 | |||||
EV-to-Revenue | 6.88 | |||||
EV-to-Forward-Revenue | 6.94 | |||||
EV-to-FCF | -1.84 | |||||
Price-to-Net-Current-Asset-Value | 1.95 | |||||
Price-to-Net-Cash | 2.51 | |||||
Earnings Yield (Greenblatt) % | -50.67 | |||||
FCF Yield % | -30.12 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
AC Immune SA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 15.694 | ||
EPS (TTM) (€) | -0.657 | ||
Beta | 0.95 | ||
Volatility % | 78.13 | ||
14-Day RSI | 29.81 | ||
14-Day ATR (€) | 0.132007 | ||
20-Day SMA (€) | 2.4655 | ||
12-1 Month Momentum % | 58.08 | ||
52-Week Range (€) | 1.6 - 4.65 | ||
Shares Outstanding (Mil) | 98.9 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
AC Immune SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
AC Immune SA Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
AC Immune SA Frequently Asked Questions
What is AC Immune SA(FRA:IMR)'s stock price today?
When is next earnings date of AC Immune SA(FRA:IMR)?
Does AC Immune SA(FRA:IMR) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |